CASSAVA SCIENCES INC·4

Oct 4, 6:29 PM ET

Kupiec James William 4

4 · CASSAVA SCIENCES INC · Filed Oct 4, 2023

Insider Transaction Report

Form 4
Period: 2023-10-03
Kupiec James William
Chief Clinical Dev. Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-10-03+150,000150,000 total
    Exercise: $17.54Exp: 2033-10-03Common Stock (150,000 underlying)
Footnotes (1)
  • [F1]The stock option vests over three (3) years at a rate of 1/36th each month.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4